Bioeq IP AG’s Lucentis Biosimilar Out-Licensing To Coherus BioSciences, Inc.

Freshfields Bruckhaus Deringer LLP has advised Bioeq IP AG on its license and development agreement with Coherus BioSciences, Inc. The agreement enables Coherus to exclusively market…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here